GE HealthCare Technologies Inc.
For the period ended Sep 30, 2025. Filed Oct 29, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2025 · Filed Oct 29, 2025
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Results of Operations – Segments
We exclude from Segment EBIT certain corporate-related expenses and certain transactions or adjustments that our Chief Operating Decision Maker (which is our Chief Executive Officer) considers to be non-operational, such as Interest and other financial charges – net, Benefit (provision) for income taxes, restructuring costs, acquisition and disposition-related benefits (charges), Spin-Off and separation costs, Non-operating benefit (income) costs, gain (loss) on business and asset dispositions, amortization of acquisition-related intangible assets, Net (income) loss attributable to noncontrolling interests, Income (loss) from discontinued operations, net of taxes, and investment revaluation gain (loss). See Note 3, “Segment Information” for additional information on our reportable segments, and “Results of Operations” above for discussion on segment revenue performance.
| Segment EBIT | For the three months ended September 30 | For the nine months ended September 30 | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 2025 | % of segment revenues | 2024 | % of segment revenues | % change | 2025 | % of segment revenues | 2024 | % of segment revenues | % change | |
| Imaging | $240 | 10.2% | $287 | 12.9% | (16)% | $627 | 9.4% | $660 | 10.2% | (5)% |
| AVS | 271 | 20.9% | 232 | 19.0% | 17% | 799 | 20.9% | 744 | 20.2% | 7% |
| PCS | 27 | 3.7% | 82 | 10.6% | (67)% | 135 | 6.0% | 241 | 10.5% | (44)% |
| PDx | 220 | 29.4% | 193 | 30.9% | 14% | 638 | 30.3% | 571 | 30.6% | 12% |
Imaging Segment EBIT was $240 million, a decrease of $46 million due to cost inflation, including the impact of incremental tariffs, partially offset by a growth in sales volume;
AVS Segment EBIT was $271 million, an increase of $40 million due to growth in sales volume and cost productivity, partially offset by cost inflation, including the impact of incremental tariffs;
PCS Segment EBIT was $27 million, a decrease of $55 million due to a decline in sales volume, cost inflation, including the impact of incremental tariffs, and unfavorable mix; and
PDx Segment EBIT was $220 million, an increase of $27 million due to an increase in price and growth in sales volume, partially offset by increased investment.
Imaging Segment EBIT was $627 million, a decrease of $33 million due to cost inflation, including the impact of incremental tariffs, partially offset by a growth in sales volume, cost productivity, and an increase in price;
AVS Segment EBIT was $799 million, an increase of $55 million due to growth in sales volume and cost productivity, partially offset by cost inflation, including the impact of incremental tariffs;
PCS Segment EBIT was $135 million, a decrease of $106 million due to cost inflation, including the impact of incremental tariffs, unfavorable mix, and a decline in sales volume; and
PDx Segment EBIT was $638 million, an increase of $68 million due to an increase in price and growth in sales volume, partially offset by increased investment.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.